Modeling the impact of interventions along the HIV continuum of care in Newark, New Jersey.

BACKGROUND The human immunodeficiency virus (HIV) epidemic in Newark, New Jersey, is among the most severe in the United States. Prevalence ranges up to 3.3% in some groups. The aim of this study is to use a mathematical model of the epidemic in Newark to assess the impact of interventions along the continuum of care, leading to virologic suppression. METHODS A model was constructed of HIV infection including specific care-continuum steps. The model was calibrated to HIV/AIDS cases in Newark among different populations over a 10-year period. Interventions applied to model fits were increasing proportions tested, linked and retained in care, linked and adherent to treatment, and increasing testing frequency, high-risk-group testing, and adherence. Impacts were assessed by measuring incidence and death reductions 10 years postintervention. RESULTS The most effective interventions for reducing incidence were improving treatment adherence and increasing testing frequency and coverage. No single intervention reduced incidence in 2023 by >5%, and the most effective combination of interventions reduced incidence by approximately 16% (2%-24%). The most efficacious interventions for reducing deaths were increasing retention, linkage to care, testing coverage, and adherence. Increasing retention reduced deaths by approximately 27% (24%-29%); the most efficacious combination of interventions reduced deaths in 2023 by approximately 52% (46%-57%). CONCLUSIONS Reducing HIV deaths in Newark over a 10-year period may be a realizable goal, but reducing incidence is less likely. Our results highlight the importance of addressing leaks across the entire continuum of care and reinforcing efforts to prevention new HIV infections with additional interventions.

[1]  R. Walensky,et al.  Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  William C Miller,et al.  The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study , 2011, The Lancet.

[3]  Neil M Ferguson,et al.  Modelling the Impact of Antiretroviral Use in Resource-Poor Settings , 2006, PLoS medicine.

[4]  A. Lansky,et al.  Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors--United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. , 2006, Morbidity and mortality weekly report. Surveillance summaries.

[5]  Stephen W. Sorensen,et al.  A Mathematical Model of Comprehensive Test-and-Treat Services and HIV Incidence among Men Who Have Sex with Men in the United States , 2012, PloS one.

[6]  Christopher Dye,et al.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.

[7]  Kenneth H Mayer,et al.  AIDS in America--forgotten but not gone. , 2010, The New England journal of medicine.

[8]  B. Branson The Future of HIV Testing , 2010, Journal of acquired immune deficiency syndromes.

[9]  T. Hallett,et al.  Examining the promise of HIV elimination by ‘test and treat’ in hyperendemic settings , 2010, AIDS.

[10]  E H Kaplan,et al.  A model-based estimate of HIV infectivity via needle sharing. , 1992, Journal of acquired immune deficiency syndromes.

[11]  P. Vanhems,et al.  CD4 decline in seroconverter and seroprevalent individuals in the precombination of antiretroviral therapy era , 2010, AIDS.

[12]  W. Levine,et al.  The transmission dynamics of gonorrhoea: modelling the reported behaviour of infected patients from Newark, New Jersey. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[13]  R. Royce,et al.  Sexual transmission of HIV. , 1997, The New England journal of medicine.

[14]  References , 1971 .

[15]  M. Cribbin,et al.  HIV risk, prevention, and testing behaviors among men who have sex with men--National HIV Behavioral Surveillance System, 21 U.S. cities, United States, 2008. , 2011, Morbidity and mortality weekly report. Surveillance summaries.

[16]  David Wypij,et al.  The prevalence of homosexual behavior and attraction in the United States, the United Kingdom and France: Results of national population-based samples , 1995, Archives of sexual behavior.

[17]  A. Adimora,et al.  HIV Acquisition Among Women From Selected Areas of the United States , 2013, Annals of Internal Medicine.

[18]  O. Laeyendecker,et al.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. , 2005, The Journal of infectious diseases.

[19]  Carlos Del Rio,et al.  The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  Anne M Johnson,et al.  Time from human immunodeficiency virus seroconversion to reaching CD4+ cell count thresholds <200, <350, and <500 Cells/mm³: assessment of need following changes in treatment guidelines. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Jose A. Gonzalez,et al.  DEPARTMENT OF HEALTH AND SENIOR SERVICES , 2011 .

[22]  B. Branson,et al.  Vital signs: HIV prevention through care and treatment--United States. , 2011, MMWR. Morbidity and mortality weekly report.

[23]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[24]  R. Anderson,et al.  Sexual contact patterns between men and women and the spread of HIV-1 in urban centres in Africa. , 1991, IMA journal of mathematics applied in medicine and biology.

[25]  Hadi Dowlatabadi,et al.  Sensitivity and Uncertainty Analysis of Complex Models of Disease Transmission: an HIV Model, as an Example , 1994 .

[26]  Margaret L. Brandeau,et al.  The Cost-Effectiveness and Population Outcomes of Expanded HIV Screening and Antiretroviral Treatment in the United States , 2010, Annals of Internal Medicine.

[27]  L. Cheever Engaging HIV-infected patients in care: their lives depend on it. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  Geoffrey P Garnett,et al.  Treating our way out of the HIV pandemic: could we, would we, should we? , 2009, The Lancet.

[29]  Rachel Jones,et al.  Young Urban Women’s Patterns of Unprotected Sex with Men Engaging in HIV Risk Behaviors , 2007, AIDS and Behavior.

[30]  S. Vermund,et al.  Rethinking prevention of HIV type 1 infection. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Christophe Fraser,et al.  HIV-1 transmission, by stage of infection. , 2008, The Journal of infectious diseases.